Is NPCE up or down today?
NPCE is down 10.91% today, last at 13.64. This stock moved -10.91% versus the prior close.
NPCE · NPCE
NPCE (NPCE) is trading at 13.64, down 10.91% on the session. Price action shows weakness or stretched conditions worth watching.
Over the past 7 days, 23 headlines skew mixed. Macro/Market and Earnings themes dominated coverage. Stories with measurable price impact averaged -6.45% — headlines dragged the stock.
Social mentions lean cautious or negative.
Analyst firms are mostly reiterating — no strong directional shift lately.
NPCE is down 10.91% today, last at 13.64. This stock moved -10.91% versus the prior close.
Over the past 7 days, 23 headlines skew mixed. Macro/Market and Earnings themes dominated coverage. Stories with measurable price impact averaged -6.45% — headlines dragged the stock. Dominant story: NeuroPace (NASDAQ:NPCE) Gains A Fresh Regulatory Catalyst - Kalkine Media (1 source, bullish) RSI is 33 — leaning bearish Price below 50-day average — short-term weakness Social (demo): 37% of recent mentions lean bullish — social mood is cautious.
Loaded: Feb 2026 – Jul 2026 (123 days) · Drag or scroll left for earlier dates
Analyst firms are mostly reiterating — no strong directional shift lately.
Query: NPCE
0/ 100 index
Based on 11,206 mentions over 30d
NeuroPace (NASDAQ:NPCE) Gains A Fresh Regulatory Catalyst - Kalkine Media
NeuroPace drops as FDA denies bid to expand RNS System - Seeking Alpha
NeuroPace drops as bid to expand label for RNS System denied in U.S.
H.C. Wainwright reiterates Buy on NeuroPace stock after FDA feedback - Investing.com
HC Wainwright Reaffirms Buy Rating for NeuroPace (NASDAQ:NPCE) - MarketBeat